Research Article
A Reappraisal of Women’s Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50–59 Years of Age
Table 4
Women 50–59 years of age at trial entry, WHI Estrogen-Alone Trial Outcomes, intervention phase and postintervention phase, events, and relative risk.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hazard ratios in WHI Hormone Trials apply a time to event analysis which can not be duplicated without full access to the data set. Relative risks in this table are calculated and shown (no time to event analysis) to allow comparison of the intervention phase and post intervention phase data. aGlobal index represents the first event for each participant from among the following: coronary heart disease, stroke, pulmonary embolism, invasive breast cancer, colorectal cancer, hip fracture, or death due to other causes. CEE, conjugated equine estrogens; CHD, coronary heart disease; CI, confidence interval; MI, myocardial infarction; RR, relative risk; WHI, Women’s Health Initiative. Source for the number of events and number of participants: [3, 12]. |